Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/20/2002WO2002048348A1 Novel gene existing in human leukocyte antigen domain
06/20/2002WO2002048338A2 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
06/20/2002WO2002048337A2 Secreted human proteins
06/20/2002WO2002048334A2 P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof
06/20/2002WO2002048324A1 Regulation of human ubiquitin-conjugating enzyme e2
06/20/2002WO2002048319A1 Telomerase immortalized human liver cell lines
06/20/2002WO2002048316A1 Method for in vitro culture of ovarian follicles
06/20/2002WO2002048315A2 Monoclonal antibody probe for detection of adhesins associated with mature endospores of pasteuria spp.
06/20/2002WO2002048193A2 Camelidae antibody arrays
06/20/2002WO2002048188A1 Plasmodium aldolase polypeptides and nucleic acids
06/20/2002WO2002048184A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
06/20/2002WO2002048182A2 Interferon-alpha induced gene
06/20/2002WO2002048167A1 Method for generating immortal dendritic cell lines
06/20/2002WO2002048139A2 Oxazolidinone photoaffinity probes
06/20/2002WO2002048022A1 Deflection actuator, optical scanning device, light-receiving scanning device, and image pick-up apparatus
06/20/2002WO2002047721A1 Silensed anti-cd28 antibodies and use thereof
06/20/2002WO2002047673A2 Methods and compositions to treat conditions associated with neovascularization
06/20/2002WO2002047670A1 Treatment of male sexual dysfunction
06/20/2002WO2002047613A2 Immunogenic cancer peptides and uses thereof
06/20/2002WO2002047610A2 Marine actinomycete taxon for drug and fermentation product dicovery
06/20/2002WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/20/2002WO2002047466A2 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
06/20/2002WO2002047460A2 Mass spectrometric multivariate analysis of asphalts
06/20/2002WO2002034110A3 Method of determining global coagulability and hemostatic potential
06/20/2002WO2002031185A8 Method of identifying abnormal immune reactions
06/20/2002WO2002027316A3 Methods and kits for decreasing interferences of assays samples containing plasma or serum in specific binding assays by using a large polycation
06/20/2002WO2002025288A3 Highly sensitive proteomic analysis methods and kits and systems for practicing the same
06/20/2002WO2002022856A3 Uses of the mammalian ccl18 and related reagents
06/20/2002WO2002020464A3 Benzene tricarboxylic acid amides as insulin receptor activators
06/20/2002WO2002008751A8 Mild enrichment of foetal cells from peripheral blood and use thereof
06/20/2002WO2002004477A8 Combination of microporous membrane and solid support for microdiagnostics
06/20/2002WO2002003911A8 Prevention and treatment of alzheimer's disease
06/20/2002WO2002002000A3 Methods of screening for alzheimer's disease
06/20/2002WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use
06/20/2002WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications
06/20/2002WO2001094613A3 Methods and compounds for influencing beta3 integrin-dependent intracellular processes
06/20/2002WO2001092876A3 Method for identifying compounds for modulating the activity of a tumour suppressor protein
06/20/2002WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays
06/20/2002WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
06/20/2002WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/20/2002WO2001089696A3 Microfluidic concentration gradient loop
06/20/2002WO2001086292A3 Ipg assay
06/20/2002WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path
06/20/2002WO2001085942A3 Cytoskeleton-associated proteins
06/20/2002WO2001085941A3 Myc targets
06/20/2002WO2001085096A3 Mast cell regulation
06/20/2002WO2001083524A3 Rna metabolism proteins
06/20/2002WO2001077379A3 A method of cell detection
06/20/2002WO2001077164A3 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
06/20/2002WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same
06/20/2002WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
06/20/2002WO2001069230A3 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
06/20/2002WO2001065254A3 Method for analysis of substances in tissue or in cells
06/20/2002WO2001056590A3 Utilization of protein kinase inhibitor alpha
06/20/2002WO2001052718A3 Diet and activity monitoring device
06/20/2002WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer
06/20/2002WO2001048236A9 METHODS FOR IDENTIFYING AGENTS CAPABLE OF MODULATING PROTEIN KINASE C THETA (PKCυ) ACTIVITY
06/20/2002WO2001044445A8 Human lyases and associated proteins
06/20/2002WO2001042473B1 Device and method for accelerated hydration of dry chemical sensors
06/20/2002WO2001030936A3 Composition for marking a solid or liquid product, method for making same
06/20/2002WO2000077245A9 Cell-based assay for screening cox-2 inhibitors
06/20/2002WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof
06/20/2002WO2000073792A9 Control for methods for determining platelet count and platelet function
06/20/2002WO2000072005A9 Detection of wear-particles and other impurities in industrial or other fluids
06/20/2002WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
06/20/2002WO2000061596A8 50 human secreted proteins
06/20/2002WO2000060126A3 Quantitative assay for expression of genes in microarray
06/20/2002WO2000056774A9 Methods of using bioelastomers
06/20/2002WO2000052210A9 Methods for targeting rna molecules
06/20/2002WO2000050596A9 14273 receptor, a novel g-protein coupled receptor
06/20/2002US20020078473 Pesticides
06/20/2002US20020077795 System, method and storage medium for predicting impact performance of thermoplastic
06/20/2002US20020077777 Method for monitoring a public water treatment system
06/20/2002US20020077775 Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
06/20/2002US20020077765 Indirect calorimetry system
06/20/2002US20020077758 System for control of blood processor
06/20/2002US20020077756 Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
06/20/2002US20020077755 Clinical-examination-numerical-data-processing system and recording medium for diagnostic program using the system
06/20/2002US20020077754 Pharmacophore fingerprinting in primary library design
06/20/2002US20020077584 Device and method for enhancing transdermal flux of agents being sampled
06/20/2002US20020077487 As labeling reagents for a variety of biological applications
06/20/2002US20020077468 Corticotropin-releasing factor2 receptors
06/20/2002US20020077465 Nuceotide sequences coding enzymatic polypeptide for use in the treatment and prevention of inflammation, cancer, muuscle disorders and thrombosis
06/20/2002US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
06/20/2002US20020077458 Nucleotide sequences for use in the diagnosis, treatment and prevention of apoptosis defects
06/20/2002US20020077455 Protease inhibitors
06/20/2002US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis
06/20/2002US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders
06/20/2002US20020077305 Genetic immunization with cationic lipids
06/20/2002US20020077297 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring
06/20/2002US20020077296 High-throughput screening method
06/20/2002US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease
06/20/2002US20020077273 Methods of using agents that modulate bone formation and inhibit adipogenesis
06/20/2002US20020077272 Contacting bacteria with an agent that alters the bacteria's native level of DNA methyltransferase (Dam) activity thereby altering the bacteria's native level of methylation of adenine in a GATC tetranucleotide of the bacteria
06/20/2002US20020076835 Solid support for use in the purification of protein from sample
06/20/2002US20020076834 Immunological detection of celiac disease; obtain body fluids, incubate with antibodies, monitor sample for immunological response to the presence of tissue transglutaminases
06/20/2002US20020076833 Analysis of biological samples utilizing a coated solid phase
06/20/2002US20020076832 Generating active solid support; obtain support, expose to bromoacetamidosilane, monitor support
06/20/2002US20020076831 Test piece, analysis method using the test piece, and analysis system used for the method
06/20/2002US20020076830 Fluorescence immunoassays using organo-metallic complexes for energy transfer
1 ... 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 ... 3937